The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide

Journal of Hypertension

Volumn 20, Issue 10, 2002, Pages 2023-2027

  Veldman, Bart A ^a   Spiering, Wilko ^a   Doevendans, Peter A ^a   Vervoort, Gerald ^a   Kroon, Abraham A ^a   De Leeuw, Peter W ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

EcNOS; Endothelium dependent vasodilation; Genetics; Nitric oxide; Norepinephrine; Plethysrnography

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT; DIPEPTIDE; ENZYME INHIBITOR; GAMMA GLUTAMYLASPARTIC ACID; GAMMA-GLUTAMYLASPARTIC ACID; NOS3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; FOREARM BLOOD FLOW; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; VEIN OCCLUSION PLETHYSMOGRAPHY; ADOLESCENT; BLOOD FLOW; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FOREARM; GENETIC POLYMORPHISM; GENETICS; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; REFERENCE VALUE; VASCULARIZATION;

ADOLESCENT; ADULT; ALLELES; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FOREARM; GENOTYPE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; POLYMORPHISM, GENETIC; REFERENCE VALUES; REGIONAL BLOOD FLOW; VASOCONSTRICTOR AGENTS;

EID: 0036808187     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200210000-00022     Document Type: Article

References (23)

1. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996; 78:225-230.
2. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83:1774-1777.
3. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2:1057-1058.
4. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-4655.
5. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 1993; 334:170-174.
6. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999; 33:937-942.
7. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999; 33:933-936.
8. Schneider MP, Erdmann J, Delles Ch, Fleck E, Regitz-Zagrosek V, Schmieder RE. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens 2000; 18:1767-1773.
9. G-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans. J Cardiovasc Pharmacol 1993; 22:884-888.
10. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999; 9:936-949.
11. Willemsen JJ, Ross HA, Jacobs MC, Lenders JW, Thien T, Swinkels LM, et al. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem 1995; 41:1455-1460.
12. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993; 39:263-271.
13. Demacker PN, Hijmans AG, Vos-Janssen HE, van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980; 26:1775-1779.
14. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man [see comments]. Lancet 1989; 2:997-1000.
15. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96:418-424.
16. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32:3-8.
17. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16:31-35.
18. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100:1515-1520.
19. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103:65-69.
20. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Artefioscler Thromb 1994; 14:753-759.
21. Rongen GA, Smits P, Thien T. Characterization of ATP-induced vasodilation in the human forearm vascular bed. Circulation 1994; 90:1891-1898.
22. Veldman B, Rongen G. Functional gene testing of the Glu298Asp polymorphism of the endothelial nitric oxide synthase. J Hypertens 2001; 19:1341-1342.
23. Philip I, Plantefeve G, Vuillaumier BS, Vicaut E, LeMarie C, Henrion D, et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999; 99:3096-3098.